Leukemia Clinical Trials in Houston

Showing 1421-1435 of 1,435 trials

Safer Choices 2 - HIV, STD, & Pregnancy Prevention Program

NCT00223314

The purpose of the study is to adapt, implement, and evaluate an effective theoretically-based, high school HIV prevention program,Safer Choices, for higher risk youth in alternative schools. Primary Research Question 1\. Did the intervention reduce the number of occasions of unprotected sexual intercourse, number of sexual partners, and the proportion of students currently sexually active among those receiving the multiple component intervention relative to those students in the comparison group?

HIVSexually Transmitted DiseasesPregnancy+1 more

The University of Texas Health Science Center, Houston1,000 participantsStarted Nov 2000

Houston, Texas, United States

TERMINATEDPhase 1< 1 mile

Study to Evaluate MEDI-507 in Patients With CD2-Positive Lymphoma/Leukemia

NCT00105313

For primary objectives, we will determine the MTD and examine clinical responses and immune cell populations to determine an OBD, and describe the safety and tolerability of MEDI-507. For the secondary objectives we will look at the antitumor activity of MEDI 507, PK, serum concentrations, and immunogenicity of MEDI-507, as well as time courses of depletion and recovery of CD2 positive and total T-Cell populations.

LymphomaLeukemiaCancer

MedImmune LLC80 participantsStarted Feb 2005

Los Angeles, California, United States • New Haven, Connecticut, United States • Washington D.C., District of Columbia, United States +8 more locations

Safer Choices 2 - HIV, STD, & Pregnancy Prevention Program

Study to Evaluate MEDI-507 in Patients With CD2-Positive Lymphoma/Leukemia

Leukemia Trials in Other Cities

Study of Neurologic Progression With Motexafin Gadolinium and Radiation Therapy (SMART)

Study Evaluating Mylotarg (Gemtuzumab Ozogamicin) in Usual Care

Autologous T Cell Immunotherapy for Chronic Lymphocytic Leukemia (CLL) Patients

Study for Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)

Classical Conditioning to Treat Allergic Airway Diseases

Study of Talabostat and Pemetrexed vs. Pemetrexed in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy

Study of Talabostat + Docetaxel Versus Docetaxel in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy

CP-481,715 Nickel Allergy Study.

Safety and Immunogenicity of Recombinant DNA and Adenovirus Expressing L523S Protein in Early Stage Non-Small Cell Lung Cancer

Amonafide in Combination With Cytarabine in Secondary AML

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

A Phase 2 Trial of Antisense Nucleotide to PKC-Alpha (LY900003, ISIS 3521) Plus Gemcitabine and Carboplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer.

Study of 111In-DAC as an Medical Imaging Agent for Lung Cancer and Brain Cancer Consistent With Metastatic Lung Cancer

Other Conditions in Houston